Hemodialysis Modulates Gene Expression Profile in Skeletal Muscle

American Journal of Kidney Diseases

Volumn 48, Issue 4, 2006, Pages 616-628

  Shah, Vallabh O ^a   Dominic, Elizabeth A ^a   Moseley, Pope ^a   Pickett, Gavin ^a   Fleet, Margret ^a   Ness, Scott ^a   Raj, Dominic S C ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

apoptosis; inflammation; Microarray; muscle wasting; transcription

Indexed keywords

GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; PHOSPHODIESTERASE IV; PROTEIN;

APOPTOSIS; ARTICLE; CELL CYCLE REGULATION; CELL PROLIFERATION; CELL ULTRASTRUCTURE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE MAPPING; GENETIC ANALYSIS; GENETIC LINKAGE; HEMODIALYSIS; HUMAN; HUMAN TISSUE; MUSCLE BIOPSY; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAMPLE SIZE; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TRANSCRIPTION REGULATION; UNINDEXED SEQUENCE; UPREGULATION; UREMIA; VASTUS LATERALIS MUSCLE;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ADULT; APOPTOSIS; CCAAT-ENHANCER-BINDING PROTEIN-DELTA; CELL CYCLE; CELL CYCLE PROTEINS; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION PROFILING; GENES, TUMOR SUPPRESSOR; HUMANS; IMMEDIATE-EARLY PROTEINS; INFLAMMATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; MUSCLE, SKELETAL; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RENAL DIALYSIS; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION; UREMIA;

EID: 33748884516     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2006.05.032     Document Type: Article

References (28)

1. Saito-Hisaminato A., Katagiri T., Kakiuchi S., Nakamura T., Tsunoda T., and Nakamura Y. Genome-wide profiling of gene expression in 29 normal human tissues with a cDNA microarray. DNA Res 9 (2002) 35-45
2. Raj D.S.C., Dominic E.A., Pai A., et al. Skeletal muscle, cytokines and oxidative stress in end-stage renal disease. Kidney Int 68 (2005) 2338-2344
3. Yang X., Pratley R.E., Tokraks S., Bogardus C., and Permana P.A. Microarray profiling of skeletal muscle tissues from equally obese, non-diabetic insulin-sensitive and insulin-resistant Pima Indians. Diabetologia 45 (2002) 1584-1593
4. Floyd M., Ayyar D.R., Barwick D.D., Hudgson P., and Weightman D. Myopathy in chronic renal failure. Q J Med 43 (1974) 509-524
5. Lazaro R.P., and Kirshner H.S. Proximal muscle weakness in uremia. Case reports and review of the literature. Arch Neurol 37 (1980) 555-558
6. Campistol J.M. Uremic myopathy. Kidney Int 62 (2002) 1901-1913
7. Kouidi E., Albani M., Natsis K., et al. The effects of exercise training on muscle atrophy in haemodialysis patients. Nephrol Dial Transplant 13 (1998) 685-699
8. Shah A.J., Sahgal V., Quintanilla A.P., Subramani V., Singh H., and Hughes R. Muscle in chronic uremia-A histochemical and morphometric study of human quadriceps muscle biopsies. Clin Neuropathol 2 (1983) 83-89
9. Raj D.S.C., Shah H., Shah V., et al. Markers of inflammation, proteolysis and apoptosis in ESRD. Am J Kidney Dis 42 (2003) 1212-1220
10. Eisen M.B., Spellman P.T., Brown P.O., and Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 95 (1998) 14863-14868
11. Sanoudou D., Kang P.B., Haslett J.N., Han M., Kunkel L.M., and Beggs A.H. Transcriptional profile of postmortem skeletal muscle. Physiol Genomics 16 (2004) 222-228
12. Tusher V.G., Tibshirani R., and Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98 (2001) 5116-5121
13. Benjamini Y., and Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc B 57 (1995) 289-300
14. Jagoe R.T., Lecker S.H., Gomes M., and Goldberg A.L. Patterns of gene expression in atrophying skeletal muscles: Response to food deprivation. FASEB J 16 (2002) 1697-1712
15. Siripurapu V., Meth J., Kobayashi N., and Hamaguchi M. DBC2 significantly influences cell-cycle, apoptosis, cytoskeleton and membrane-trafficking pathways. J Mol Biol 346 (2005) 83-89
16. Hoffmann R., and Valencia A. A gene network for navigating the literature. Nat Genet 36 (2004) 664
17. Matsuda S., Rouault J., Magaud J., and Berthet C. In search of a function for the TIS21/PC3/BTG1/TOB family. FEBS Lett 497 (2001) 67-72
18. Ruel M., Bianchi C., Khan T.A., et al. Gene expression profile after cardiopulmonary bypass and cardioplegic arrest. J Thorac Cardiovasc Surg 126 (2003) 1521-1530
19. De Smaele E., Zazzeroni F., Papa S., et al. Induction of gadd45beta by NF-kappaB downregulates pro-apoptotic JNK signalling. Nature 414 (2001) 308-313
20. Ranjan R., Shah H., Siu J., et al. Monocyte apoptosis in dialysis patients is Fas ligand-mediated. Clin Nephrol 58 (2002) 423-430
21. Sreekumar R., Halvatsiotis P., Schimke J.C., and Nair K.S. Gene expression profile in skeletal muscle of type 2 diabetes and the effect of insulin treatment. Diabetes 51 (2002) 1913-1920
22. Raj D.S., Welbourne T., Dominic E.A., Waters D., Wolfe R., and Ferrando A. Glutamine kinetics and protein turnover in end-stage renal disease. Am J Physiol Endocrinol Metab 288 (2004) E37-E46
23. Raj D.S.C., Dominic E.A., Wolfe R.A., et al. Co-ordinated increase in albumin, fibrinogen and muscle protein synthesis during hemodialysis: Role of cytokines. Am J Physiol 286 (2004) E658-E664
24. Hollander M.C., Sheikh M.S., Yu K., et al. Activation of Gadd34 by diverse apoptotic signals and suppression of its growth inhibitory effects by apoptotic inhibitors. Int J Cancer 96 (2001) 22-31
25. Rouault J.P., Falette N., Guehenneux F., et al. Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway. Nat Genet 14 (1996) 482-486
26. Matsuda S., Kawamura-Tsuzuku J., Ohsugi M., et al. Tob, a novel protein that interacts with p185erbB2, is associated with anti-proliferative activity. Oncogene 12 (1996) 705-713
27. Wang P., Wu P., Ohleth K.M., Egan R.W., and Billah M.M. Phosphodiesterase 4B2 is the predominant phosphodiesterase species and undergoes differential regulation of gene expression in human monocytes and neutrophils. Mol Pharmacol 56 (1999) 170-174
28. Huang A.M., Montagna C., Sharan S., Ni Y., Ried T., and Sterneck E. Loss of CCAAT/enhancer binding protein delta promotes chromosomal instability. Oncogene 23 (2004) 1549-1557